Although expression of isolated surface markers (e.g., CD34, CD117, CD90, CD25, CD7, CD56, and more) has been linked to poor prognosis in AML, the “poor prognostic immunophenotype” in AML remains elusive. The gene discussed is THY1; the disease is acute myeloid leukemia.